New Delhi, June 4 -- Drugs Controller General of India (DCGI), the country's top drug regulator, is planning a complete overhaul of medicines listed under Schedule H of the Drugs and Cosmetics Rules, 1945, which governs the sale of prescription drugs, said an official aware of the matter and documents reviewed by Mint.

Also Read | Key drugs, diagnostics run short in public health centres, govt raises alarm

The proposed revamp is driven by concerns, including a rise in antimicrobial resistance (AMR) from self-medication and rampant use of antibiotics purchased over the counter without prescription, the official said.

Schedule H includes drugs that cannot be purchased or sold on retail without a doctor's prescription. This overhaul will ...